FLUXNEUROSCIENCE

For the last 20 years, Dr. Martin has studied cerebrospinal fluid (CSF) diseases, diagnostics, and therapeutics. He is considered a leading expert on targeted CSF drug delivery... Dr. Martin has published 65+ peer-reviewed papers in the field and served as Principle Investigator for research funded by National Institute of Health (NIH), National Aeronautics and Space Administration (NASA), National Science Foundation (NSF), industry, and foundations within the field... Intrathecal / CSF drug delivery and pharmacokinetics for CNS diseases, gene and cell therapy, pain, and cancer

Also known as: FluxNeuroscience, LLC